Umoove, a Jerusalem-based spinoff, created a face and eye-tracking solution that is compatible with any smartphone or tablet with a front-facing camera. The company's core technology does not require any additional hardware of any kind. Furthermore, the developed in-house medical application is also powering eye tracking research in top universities across the world. Eye tracking and digital biomarkers are used as a method for diagnosis and therapy of many neurological disorders such as Attention deficit hyperactivity disorder (ADHD), concussions, traumatic brain injury, Alzheimer's disease (lat. morbus Alzheimerianus), autism (lat. Autismus), strokes (lat. Apoplexia), amyotrophic lateral sclerosis (amyotrophic lateralibus lumbos) and more. The company's first product, uHealth, was released in 2015.